TP53 and maternal uniparental disomy of chromosome 20: In a study of 60 metaplastic breast cancers (MBCs) of varying chemical composition, hTERT promoter mutations and gene amplification were less common in MBCs with predominant chondroid differentiation and were mutually exclusive with TP53 mutations [18].